Good Start Genetics Molecular Loop Acquires Inversion Probe Tech From Invitae The company plans to use the technology, originally developed by Good Start Genetics, to offer sample preparation solutions and data analysis for NGS. Invitae's Transition to 'Genomic Information Company' Likely to Include More M&A Activity Premium Invitae is interested in companies that can contribute positively to its revenues in the next two to three quarters, according to CEO Sean George. Invitae Acquires Good Start Genetics, CombiMatrix The acquisitions will enable Invitae to add reproductive health genetic testing to its portfolio and become what it calls a "comprehensive genomic information company." Telegenomics Startup Genome Medical Launches Genetic Consultation Network, Plans Service Expansion Premium Dubbing itself a "telegenomics company," San Francisco startup Genome Medical announced the launch this week of its genetic consultation services offering. Good Start Genetics Signs Coverage Agreement with BCBS of Texas The company said it now has payor coverage for more than 130 million individuals. Jan 11, 2017 Good Start Genetics, Genome Medical Form Genetic Counseling Partnership Dec 5, 2016 Roche to Sell Good Start Genetics' Carrier Screening Test Service Nov 2, 2016 Good Start Genetics Selling Carrier Screening Tests Through Amazon Feb 1, 2016 Good Start Genetics, Evidera Publish Data Demonstrating Cost Effectiveness of NGS Carrier Screening Jan 11, 2016 Consumer Genomics Firm Helix Inks Partnerships With Good Start Genetics, Duke University Oct 14, 2015 Good Start Genetics, UnitedHealthcare Pen Agreement for Genetic Screening Services Sep 29, 2015 Good Start Enters PGS Field with EmbryVu Test Premium May 14, 2015 Good Start Genetics Data Supports NGS-based Pan-Ethnic Carrier Screening Premium Apr 13, 2015 Good Start Genetics Expands Hopkins Aneuploidy Screening License to Enter NIPT Market Jan 20, 2015 Reproductive Health Science Scales up Array Manufacturing to Support EmbryoCellect Test Premium Dec 16, 2014 Good Start Genetics Expands into PGS with Goal of Entering NIPT Market Premium Dec 10, 2014 Good Start Genetics, IviGen, iGenomix Ink Exclusive Reproductive Genetics Pact Dec 8, 2014 Good Start Genetics Licenses PGS Technology from Johns Hopkins Oct 17, 2014 IP Update: IBM, Good Start Genetics among Recent Bioinformatics Patent Winners Premium Jul 17, 2014 IP Watch: Qiagen, Illumina, Canon, Others Win US Patents Premium Mar 17, 2014 Good Start Genetics, PerkinElmer Ink Deal to Broaden Access to Genetic Carrier Screening Tests Jan 15, 2014 JP Morgan Healthcare Conference, Day Two: Good Start Genetics, RainDance Technologies, Cellular Dynamics Jan 13, 2014 Good Start Signs Coverage Agreement with Tufts Health for NGS Carrier Screening Test Oct 2, 2013 People in the News: Jerry Parrott, Jonathan Drachman, Eric Sievers, Christoph Franz, Franz Humer Premium Sep 20, 2013 People in the News: Mark Adams Premium Load More Breaking News Epic Sciences, Biosplice Therapeutics Partner on Multiomic Profiling for Cancer Trials Hamilton, Pacific Biosciences Partner on Automating DNA Sample Prep Danaher Q4 Revenues Rise 21 Percent COVID-19 Severity Biomarker Candidates Revealed in RNA Sequencing Study Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent The Scan Time to Sit Back and Relax NPR reports that the US National Institutes of Health has transferred the last of its eligible, former research chimpanzees to a sanctuary. Omicron-Focused Vaccines The New York Times reports both Pfizer-BioNTech and Moderna have launched trials of SARS-CoV-2 vaccines targeting the Omicron variant. Nature Papers Present Cloud-Computing Analysis Approach, Transcription Factor With Role in Bacterial Genome Organization In Nature this week: researchers describe the free, open-source cloud-computing infrastructure Serratus and more. Time to Act A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian.